Background Subcutaneous implantable cardioverter‐defibrillators (S‐ICDs) have been of
great interest as an alternative to transvenous implantable cardioverter‐defibrillators (TV …

The subcutaneous implantable cardioverter defibrillator (S-ICD) is a completely
extrathoracic device that has recently been FDA approved for the prevention of sudden …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to reduce short-and long-term complications associated with transvenous ICD leads. Early …

Objectives: This study aims to conduct a meta-analysis comparing efficacy and safety
outcomes between subcutaneous implantable cardioverter-defibrillator (S-ICD) and …

Background Implantable cardioverter-defibrillator (ICD) placement is a well-established
therapy for prevention of sudden cardiac death. The subcutaneous implantable cardioverter …

The subcutaneous implantable cardioverter-defibrillator (S-ICD) system is an established
therapy for prevention of sudden cardiac death (SCD) and an alternative to a transvenous …

The use of cardiac implantable electronic devices (CIEDs) has continued to rise along with
indications for their removal. When confronted with challenging clinical scenarios such as …

Background: Implantable cardioverter-defibrillator (ICD) indications for primary prevention in
Brugada syndrome (BrS) are still debated. Objectives: The authors investigated the long …

Introduction Experience with the subcutaneous implantable cardioverter‐defibrillator (S‐
ICD) is expanding rapidly. However, data on long‐term performance or complications …

Introduction Comparison data on management of device‐related complications and their
impact on patient outcome and healthcare utilization between subcutaneous implantable …